Keep Track of Your Investments

Article

The Dow Jones Industrial Average may be the best-known stock market measure, but most savvy investors compare their mutual fund's performance to other indexes. One of the most popular is the S&P 500,

“You are neither right nor wrong because the crowd disagrees with you. You are right because your data and reasoning are right.”—Warren Buffett

The Dow Jones Industrial Average may be the best-known stock market measure, but most savvy investors compare their mutual fund’s performance to other indexes. One of the most popular is the Standard & Poor's 500, which measures a much broader segment of the market, tracking 500 big-company stocks to the Dow’s 30 blue chips.

The index has its downsides, however. Because it is weighted by market value, price shifts for large companies like GE and IBM have a greater impact on the index than moves in the overall market. A down day for those companies would put a drag on the 500 index that could offset some or all of a rise in most of the other stocks in the group.

But even the 500 isn’t the most effective way to measure some other market segments. If you want to see how well your small-cap stock fund is doing, you might be better off comparing its results to the Russell 2000 index. For a snapshot of the big names in the tech sector, like Microsoft and Intel, the NASDAQ 100 may be a better gauge than the 4,500-stock NASDAQ composite. For a picture of the entire stock market, take a look at the Wilshire 5000 Index.

There are several other indices that track stocks on a global or regional basis and indices that follow stocks in a particular country or industry. For a fairly complete list of all the stock market indices worldwide, check out here.

9.5%Ten-year average annual return for the Dow Jones Industrial Average.(Djindexes.com, 2008)

Read More:

DJIA History

Introduction to Stock Indexes

The Doctors' 7 Investment Principles

Timeless Investing Lessons

Learn from the Masters

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.